Arsenic-induced dysfunction in relaxation of blood vessels

Lee, MY; Jung, BI; Chung, SM; Bae, ON; Lee, JY; Park, JD; Yang, JS; Lee, H; Chung, JH

HERO ID

627236

Reference Type

Journal Article

Year

2003

Language

English

PMID

12676608

HERO ID 627236
In Press No
Year 2003
Title Arsenic-induced dysfunction in relaxation of blood vessels
Authors Lee, MY; Jung, BI; Chung, SM; Bae, ON; Lee, JY; Park, JD; Yang, JS; Lee, H; Chung, JH
Journal Environmental Health Perspectives
Volume 111
Issue 4
Page Numbers 513-517
Abstract Several epidemiological studies have suggested that exposure to arsenic is strongly correlated with the development of cardiovascular diseases such as hypertension. To determine whether arsenic affects vasomotor tone in blood vessels, we investigated the effect of arsenic on vasorelaxation using isolated rat aortic rings in an organ-bath system. Treatment with arsenite inhibited acetylcholine-induced relaxation of the aortic rings in a concentration-dependent manner, whereas several other arsenic species did not have any effect. Consistent with these findings, the levels of guanosine 3',5'-cyclic monophosphate (cGMP) in the aortic rings were significantly reduced by arsenite treatment. In cultured human aortic endothelial cells, treatment with arsenite resulted in a concentration-dependent inhibition of endothelial nitric oxide synthase (eNOS). In addition, higher concentrations of arsenite decreased the relaxation induced by sodium nitroprusside (an NO donor) and 8-Br-cGMP (a cGMP analog) in aortic rings without endothelium. These in vitro results indicate that arsenite is capable of suppressing relaxation in blood vessels by inhibiting eNOS activity in endothelial cells and by impairing the relaxation machinery in smooth muscle cells. In vivo studies revealed that the reduction of blood pressure by acetylcholine infusion was significantly suppressed after arsenite was administered intravenously to rats. These data suggest that an impairment of vasomotor tone due to arsenite exposure may be a contributing factor in the development of cardiovascular disease.
Doi 10.1289/ehp.5916
Pmid 12676608
Wosid WOS:000182144300040
Is Certified Translation No
Dupe Override No
Comments |WOS:000182144300040
Is Public Yes
Language Text English
Keyword arsenic; arsenite; blood vessels; cardiovascular disease; endothelial nitric oxide synthase; nitric oxide; vasorelaxation
Is Qa No